Chun Ling Zhang

Title: Innovations of Chun Ling Zhang in Tumor Radiotherapy

Introduction

Chun Ling Zhang is an accomplished inventor based in Beijing, China. He has made significant contributions to the field of tumor radiotherapy through his innovative research and development of pharmaceutical applications.

Latest Patents

Chun Ling Zhang holds a patent titled "Application of naringenin and naringin in tumor radiotherapy." This invention provides applications of a small molecular flavonoid compound in preparing a medication for sensitizing and synergizing tumor radiation therapy, as well as reducing radioactive damage. The small molecular flavonoid compounds can include naringenin, hesperetin, luteolin, and apigenin, among others. The medication comprises a small molecular flavonoid compound as the active ingredient, along with a variety of conventional pharmaceutical additives.

Career Highlights

Throughout his career, Chun Ling Zhang has worked with prestigious organizations, including the Chinese Academy of Sciences and Topfond Pharmaceutical Co., Ltd. His work has focused on enhancing the effectiveness of tumor treatments and minimizing the side effects associated with radiation therapy.

Collaborations

Chun Ling Zhang has collaborated with notable colleagues, including Wei Liang and Wen Feng Zeng, who have contributed to his research endeavors.

Conclusion

Chun Ling Zhang's innovative work in the application of flavonoid compounds for tumor radiotherapy showcases his commitment to advancing medical science. His contributions are paving the way for more effective cancer treatments and improving patient outcomes.